A Case of Healthcare‐Associated, Multidrug‐Resistant Tuberculosis in Austria: Reconsidering the Value of Cohorting of Patients with Culture‐Positive Tuberculosis
From the Austrian Agency for Health and Food Safety, Vienna (A.I., B.R., I.A., F.A.), and the Public Health Authority of the Province of Oberösterreich, Linz (E.M., S.M.), Austria.
Cohorting of patients with culture‐positive tuberculosis is still widely practiced in Austria, a country where approximately 1% of Mycobacterium tuberculosis isolates are multidrug resistant. Cohorting of patients with tuberculosis prior to determination of drug susceptibility is unacceptable because M. tuberculosis superinfection can occur.
Received May 3, 2006; accepted June 23, 2006; electronically published February 26, 2007.



